Job title: VP & Global Head of RWE & Clinical Outcomes
Javier Jimenez is a Medical Doctor, Master in Public Health and Specialist in Preventive Medicine with more than 20 years of experience in epidemiology and 15 years in Pharmaceutical Industry at the country, regional and global level. Throughout his career, Javier has applied his In-depth knowledge of epidemiology and Real World Evidence to generate the required evidence to demonstrate the value of medicines for patients, health care providers and society. By staffing, training and development of high performing teams, collaboration with internal functions and partnering with scientific societies and providers Javier led the development of a world class RWE function responsible for design and implementation of high quality innovative RWE programs.
Javier held the role of VP, Medical Evidence and Observational Research at AstraZeneca, where he was responsible for worldwide RWE strategy, Epidemiology support and delivery of Medical Evidence (RWE, Phase lllB-IV and External Sponsored Research) for the AstraZeneca portfolio. He was also a key representative on Global Medical Affairs Leadership team and Medical Affairs studies Governance committees. Most recently, Javier joined Sanofi in January 2017 to lead the RWE and Clinical Outcomes team reporting to Bernard Hamelin in the Evidence Generation team (CMO).
The mission of the RWE and CO team is to build and maintain an integrated RWE platform, source key data sets and use of analytical capabilities and partners required to generate high quality medical evidence. Champion the use of innovative medical evidence generation capabilities by GBUs, function and countries by educating them on the use of new capabilities, enhancement and collaboration to ensure the integration of RWE strategy in all projects.
Generate meaningful insights to support internal and external decision making required to ensure the best outcome for patients by appropr iate use of our products in clinical practice. Deliver innovative and impactful medical evidence required by healthcare decision makers to understand medical value of sanofi therapies by knowing our products and data best, identify gaps and potential challenges early on. Enhance external collaboration with healthcare decision makers, patients, and academic institutions to shape medical evidence generation methodology and policies
Advancing the Use of Advanced Analytics in Real World Evidence 9:15 am
• More information coming soonRead more
day: Day One
‘IMPACCT’ Panel Discussion: Advancing the Generation & Utilization of Real World Evidence to Drive Patient-Centricity & Better Outcomes 8:30 am
• Focusing on patient-centered drug development – what is the role of RWE? • Defining and establishing clinically meaningful evidence to support R&D • How to bring RWE-enhanced drug development one step forward? • Where does the biggest opportunity for next steps in this space lie? • Discussing the current regulatory climate in RWE •…Read more
day: Day One